Ceptava

Ceptava is an oral medication containing mycophenolate sodium, used for immunosuppressive therapy. It helps manage certain autoimmune conditions and prevent organ rejection post-transplant.

Ceptava is primarily used to prevent organ rejection in transplant patients. It works by suppressing the immune system to reduce the risk of the body rejecting a transplanted organ. Additionally, it may be prescribed for certain autoimmune conditions where immune system modulation is necessary.

Common effects of Ceptava may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience fatigue or an increased susceptibility to infections due to its immunosuppressive properties. Always consult a healthcare provider for personalized advice.

Ceptava should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause birth defects. Regular monitoring of blood cell counts and liver function is advisable. Avoid live vaccines while taking this medication.

Ceptava may interact with other immunosuppressive drugs, increasing the risk of severe infections. It is also important to avoid alcohol, as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking.